Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2016 Update

Report code: GDME5968PD

Publisher: GlobalData

Formats: PDF

Published: June 29, 2016

Number of pages: 27

Biocept, Inc. (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company caters to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Biocept, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Biocept, Inc. Company Snapshot 5

Biocept, Inc. Company Overview 5

Biocept, Inc. Pipeline Products and Clinical Trials Overview 6

Biocept, Inc. – Pipeline Analysis Overview 8

Key Facts 8

Biocept, Inc. - Major Products and Services 9

Biocept, Inc. Pipeline Products by Development Stage 10

Biocept, Inc. Pipeline Products Overview 12

CTC Based Liquid Biopsy Test – ESR1 12

CTC Based Liquid Biopsy Test – ESR1 Product Overview 12

ctDNA Based Liquid Biopsy Test - ESR1 13

ctDNA Based Liquid Biopsy Test - ESR1 Product Overview 13

MicroRNA Test - Lung Cancer 14

MicroRNA Test - Lung Cancer Product Overview 14

OncoCEE - CR (FISH) 15

OncoCEE - CR (FISH) Product Overview 15

preCEED 16

preCEED Product Overview 16

Biocept, Inc. - Key Competitors 17

Biocept, Inc. - Key Employees 18

Biocept, Inc. - Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Biocept, Inc., Recent Developments 20

May 31, 2016: Biocept Launches Liquid Biopsy Immuno-Oncology PD-L1 Test 20

May 25, 2016: High Sensitivity of Biocept's Target Selector Blood-Based Liquid Biopsy Tests Featured in Two Abstracts at ASCO 20

May 23, 2016: Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests 21

May 19, 2016: Biocept Launches Proprietary Liquid Biopsy Test to Detect RET Fusions in Patients with Lung Cancer 21

May 12, 2016: Biocept Expands Intellectual Property Portfolio with 12th Granted Patent on its Key Liquid Biopsy Technology 22

May 12, 2016: Biocept Reports 2016 First Quarter Financial Results 22

Apr 27, 2016: Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study 23

Mar 23, 2016: Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award 24

Mar 10, 2016: Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel 24

Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results 24

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27

List of Tables

List of Tables

Biocept, Inc. Pipeline Products and Clinical Trials Overview 6

Biocept, Inc. Pipeline Products by Equipment Type 6

Biocept, Inc. Pipeline Products by Indication 7

Biocept, Inc., Key Facts 8

Biocept, Inc., Major Products and Services 9

Biocept, Inc. Number of Pipeline Products by Development Stage 10

Biocept, Inc. Pipeline Products Summary by Development Stage 11

CTC Based Liquid Biopsy Test – ESR1 - Product Status 12

CTC Based Liquid Biopsy Test – ESR1 - Product Description 12

ctDNA Based Liquid Biopsy Test - ESR1 - Product Status 13

ctDNA Based Liquid Biopsy Test - ESR1 - Product Description 13

MicroRNA Test - Lung Cancer - Product Status 14

MicroRNA Test - Lung Cancer - Product Description 14

OncoCEE - CR (FISH) - Product Status 15

OncoCEE - CR (FISH) - Product Description 15

preCEED - Product Status 16

preCEED - Product Description 16

Biocept, Inc., Key Employees 18

List of Figures

List of Figures

Biocept, Inc. Pipeline Products by Equipment Type 7

Biocept, Inc. Pipeline Products by Development Stage 10

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP